Welcome to LookChem.com Sign In|Join Free

CAS

  • or

117391-50-1

Post Buying Request

117391-50-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

117391-50-1 Usage

General Description

DL-beta-(3-Bromophenyl)alanine, also known as DL-3-(3-bromophenyl)alanine, is a chemical compound with a molecular formula of C9H10BrNO2. It has molecular weight of 244.086 g/mol. DL-beta-(3-Bromophenyl)alanine falls under the category of amino acids and peptides, specifically, unusual amino acids. It is typically used in research and scientific studies rather than in any particular industrial or common household application. There is limited information on its properties and hazards, indicating that it's not very well-studied or widely used. As with all chemicals, handling should be done with appropriate safety measures.

Check Digit Verification of cas no

The CAS Registry Mumber 117391-50-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,3,9 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 117391-50:
(8*1)+(7*1)+(6*7)+(5*3)+(4*9)+(3*1)+(2*5)+(1*0)=121
121 % 10 = 1
So 117391-50-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10BrNO2/c10-7-3-1-2-6(4-7)8(11)5-9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1

117391-50-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (573450)  3-Amino-3-(3-bromophenyl)propionicacid  97%

  • 117391-50-1

  • 573450-1G

  • 1,529.19CNY

  • Detail

117391-50-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Amino-3-(3-bromophenyl)propionic acid

1.2 Other means of identification

Product number -
Other names 3-Amino-3-(3-bromophenyl)propionic Acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:117391-50-1 SDS

117391-50-1Relevant articles and documents

The kinetic resolution of oxazinones by alcoholysis: access to orthogonally protected β-amino acids

Cronin, Sarah A.,Connon, Stephen J.

supporting information, p. 7348 - 7352 (2021/09/07)

The catalytic, alcoholytic kinetic resolution of oxazinones is reported. A novel, stereochemically dense cinchona alkaloid-based catalyst can facilitate the highly enantiodiscriminatory (Sup to 101) ring-opening of oxazinones equipped with electrophilic aryl units to generate orthogonally protected β-amino acids for the first time.

Propionic Acid Derivatives and Methods of Use Thereof

-

Paragraph 1607; 1608, (2018/11/21)

Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.

Synthesis and biological evaluation of 3-phenyl-3-aryl carboxamido propanoic acid derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26A1)

Zhao, Dongmei,Sun, Bin,Ren, Jinhong,Li, Fengrong,Song, Shuai,Lv, Xuejiao,Hao, Chenzhou,Cheng, Maosheng

, p. 1356 - 1365 (2015/03/04)

All-trans-retinoic acid (ATRA), the biologically active metabolite of vitamin A, is used medicinally for the treatment of hyperproliferative diseases and cancers. However, it is easily metabolized. In this study, the leading compound S8 was found based on virtual screening. To improve the activity of the leading compound S8, a series of novel S8 derivatives were designed, synthesized and evaluated for their in vitro biological activities. All of the prepared compounds showed that substituting the 5-chloro-3-methyl-1-phenyl-1H-pyrazole group for the 2-tertbutyl-5-methylfuran scaffold led to a clear increase in the biological activity. The most promising compound 32, with a CYP26A1 IC50 value of 1.36 μM (compared to liarozole (IC50 = 2.45 μM) and S8 (IC50 = 3.21 μM)) displayed strong inhibitory and differentiation activity against HL60 cells. In addition, the study focused on the effect of β-phenylalanine, which forms the coordination bond with the heme of CYP26A1. These studies suggest that the compound 32 can be used as an appropriate candidate for future development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 117391-50-1